A detailed history of Bender Robert & Associates transactions in Illumina, Inc. stock. As of the latest transaction made, Bender Robert & Associates holds 44,961 shares of ILMN stock, worth $6.36 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares
44,961
Previous 45,990 2.24%
Holding current value
$6.36 Million
Previous $6.32 Million 25.68%
% of portfolio
1.03%
Previous 1.48%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$127.73 - $147.2 $22,225 - $25,612
-174 Reduced 0.38%
45,990 $6.32 Million
Q4 2023

Jan 31, 2024

SELL
$92.79 - $142.53 $98,450 - $151,224
-1,061 Reduced 2.25%
46,164 $6.43 Million
Q3 2023

Oct 13, 2023

SELL
$128.91 - $192.44 $89,205 - $133,168
-692 Reduced 1.44%
47,225 $6.48 Million
Q2 2023

Jul 13, 2023

SELL
$183.43 - $232.67 $349,984 - $443,934
-1,908 Reduced 3.83%
47,917 $8.98 Million
Q1 2023

Apr 20, 2023

SELL
$193.75 - $232.55 $102,493 - $123,018
-529 Reduced 1.05%
49,825 $11.6 Million
Q4 2022

Feb 02, 2023

SELL
$187.24 - $242.74 $159,715 - $207,057
-853 Reduced 1.67%
50,354 $10.2 Million
Q3 2022

Oct 26, 2022

BUY
$177.23 - $227.44 $313,165 - $401,886
1,767 Added 3.57%
51,207 $9.77 Million
Q2 2022

Jul 19, 2022

SELL
$181.58 - $368.0 $90,245 - $182,896
-497 Reduced 1.0%
49,440 $9.12 Million
Q1 2022

Apr 14, 2022

BUY
$303.87 - $423.8 $108,785 - $151,720
358 Added 0.72%
49,937 $17.4 Million
Q3 2021

Nov 09, 2021

BUY
$405.61 - $524.84 $19.9 Million - $25.8 Million
49,074 Added 9717.62%
49,579 $20.1 Million
Q3 2021

Nov 03, 2021

SELL
$405.61 - $524.84 $19.9 Million - $25.8 Million
-49,091 Reduced 98.98%
505 $314,000
Q2 2021

Jul 16, 2021

BUY
$372.84 - $481.5 $102,531 - $132,412
275 Added 0.56%
49,596 $23.5 Million
Q1 2021

Apr 28, 2021

BUY
$361.28 - $504.76 $179,917 - $251,370
498 Added 1.02%
49,321 $18.9 Million
Q4 2020

Jan 29, 2021

BUY
$292.7 - $370.96 $54,734 - $69,369
187 Added 0.38%
48,823 $18.1 Million
Q3 2020

Oct 29, 2020

SELL
$268.51 - $400.74 $98,543 - $147,071
-367 Reduced 0.75%
48,636 $15 Million
Q2 2020

Jul 31, 2020

SELL
$256.46 - $373.01 $104,892 - $152,561
-409 Reduced 0.83%
49,003 $18.1 Million
Q1 2020

Apr 21, 2020

SELL
$209.2 - $335.53 $33,053 - $53,013
-158 Reduced 0.32%
49,412 $13.5 Million
Q4 2019

Jan 31, 2020

SELL
$288.29 - $335.49 $148,469 - $172,777
-515 Reduced 1.03%
49,570 $16.4 Million
Q3 2019

Oct 15, 2019

SELL
$266.84 - $378.23 $81,919 - $116,116
-307 Reduced 0.61%
50,085 $15.2 Million
Q2 2019

Jul 30, 2019

SELL
$300.59 - $368.15 $244,379 - $299,305
-813 Reduced 1.59%
50,392 $15.2 Million
Q1 2019

Apr 30, 2019

SELL
$272.57 - $321.18 $82,861 - $97,638
-304 Reduced 0.59%
51,205 $15.9 Million
Q4 2018

Jan 24, 2019

SELL
$272.46 - $366.54 $246,303 - $331,352
-904 Reduced 1.72%
51,509 $15.4 Million
Q3 2018

Oct 17, 2018

SELL
$279.04 - $367.06 $63,342 - $83,322
-227 Reduced 0.43%
52,413 $19.2 Million
Q2 2018

Jul 27, 2018

BUY
$228.17 - $292.07 $12,777 - $16,355
56 Added 0.11%
52,640 $14.7 Million
Q1 2018

Apr 27, 2018

SELL
$209.54 - $253.91 $531,393 - $643,915
-2,536 Reduced 4.6%
52,584 $12.4 Million
Q4 2017

Jan 19, 2018

SELL
$202.23 - $230.03 $71,589 - $81,430
-354 Reduced 0.64%
55,120 $12 Million
Q3 2017

Oct 23, 2017

BUY
$172.3 - $213.93 $9.56 Million - $11.9 Million
55,474
55,474 $11.1 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.2B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Bender Robert & Associates Portfolio

Follow Bender Robert & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bender Robert & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Bender Robert & Associates with notifications on news.